Last reviewed · How we verify
Vitamin B1-ratiopharm
Vitamin B1-ratiopharm is a Vitamin B1 supplement Small molecule drug developed by Medical University of Vienna. It is currently FDA-approved for Thiamine (Vitamin B1) deficiency, Wernicke-Korsakoff syndrome, Beriberi. Also known as: Vitamin B1-ratiopharm®.
Vitamin B1 (thiamine) acts as a coenzyme in carbohydrate metabolism and nervous system function.
Vitamin B1 (thiamine) acts as a coenzyme in carbohydrate metabolism and nervous system function. Used for Thiamine (Vitamin B1) deficiency, Wernicke-Korsakoff syndrome, Beriberi.
At a glance
| Generic name | Vitamin B1-ratiopharm |
|---|---|
| Also known as | Vitamin B1-ratiopharm® |
| Sponsor | Medical University of Vienna |
| Drug class | Vitamin B1 supplement |
| Target | Thiamine pyrophosphate-dependent enzymes |
| Modality | Small molecule |
| Therapeutic area | Nutritional deficiency / Neurology |
| Phase | FDA-approved |
Mechanism of action
Thiamine is converted to thiamine pyrophosphate (TPP), which serves as an essential cofactor for several key enzymes involved in carbohydrate metabolism, including pyruvate dehydrogenase and transketolase. It is critical for energy production in cells and proper functioning of the nervous system, particularly in nerve impulse transmission and myelin formation.
Approved indications
- Thiamine (Vitamin B1) deficiency
- Wernicke-Korsakoff syndrome
- Beriberi
- Thiamine deficiency-related neurological conditions
Common side effects
- Hypersensitivity reactions
- Local injection site reactions (if parenteral)
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Vitamin B1-ratiopharm CI brief — competitive landscape report
- Vitamin B1-ratiopharm updates RSS · CI watch RSS
- Medical University of Vienna portfolio CI
Frequently asked questions about Vitamin B1-ratiopharm
What is Vitamin B1-ratiopharm?
How does Vitamin B1-ratiopharm work?
What is Vitamin B1-ratiopharm used for?
Who makes Vitamin B1-ratiopharm?
Is Vitamin B1-ratiopharm also known as anything else?
What drug class is Vitamin B1-ratiopharm in?
What development phase is Vitamin B1-ratiopharm in?
What are the side effects of Vitamin B1-ratiopharm?
What does Vitamin B1-ratiopharm target?
Related
- Drug class: All Vitamin B1 supplement drugs
- Target: All drugs targeting Thiamine pyrophosphate-dependent enzymes
- Manufacturer: Medical University of Vienna — full pipeline
- Therapeutic area: All drugs in Nutritional deficiency / Neurology
- Indication: Drugs for Thiamine (Vitamin B1) deficiency
- Indication: Drugs for Wernicke-Korsakoff syndrome
- Indication: Drugs for Beriberi
- Also known as: Vitamin B1-ratiopharm®
- Compare: Vitamin B1-ratiopharm vs similar drugs
- Pricing: Vitamin B1-ratiopharm cost, discount & access